Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Adrevil
2. Butalamine
3. La 1221
4. Surheme
1. Butalamine Hcl
2. 28875-47-0
3. 56974-46-0
4. N,n-dibutyl-n'-(3-phenyl-1,2,4-oxadiazol-5-yl)ethylenediamine Hydrochloride
5. Adrevil
6. Hemotrope
7. Surheme
8. N',n'-dibutyl-n-(3-phenyl-1,2,4-oxadiazol-5-yl)ethane-1,2-diamine;hydrochloride
9. Q7urg335cl
10. N1,n1-dibutyl-n2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethane-1,2-diamine Hydrochloride
11. La 1221
12. Einecs 249-279-2
13. N,n-dibutyl-n'-(3-phenyl-1,2,4-oxadiazol-5-yl)-1,2-ethanediamine Hydrochloride
14. Schembl1568664
15. Dtxsid70951510
16. Butalamine Hydrochloride [mi]
17. La-1221
18. Butalamine Hydrochloride [mart.]
19. Butalamine Hydrochloride [who-dd]
20. Q27287094
21. 5-((2-(dibutylamino)ethyl)amino)-3-phenyl-1,2,4-oxadiazole Hydrochloride
22. N-butyl-n-{2-[(3-phenyl-1,2,4-oxadiazol-5(2h)-ylidene)amino]ethyl}butan-1-amine--hydrogen Chloride (1/1)
| Molecular Weight | 352.9 g/mol |
|---|---|
| Molecular Formula | C18H29ClN4O |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 11 |
| Exact Mass | 352.2029893 g/mol |
| Monoisotopic Mass | 352.2029893 g/mol |
| Topological Polar Surface Area | 54.2 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 289 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
ABOUT THIS PAGE
40
PharmaCompass offers a list of Butalamine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Butalamine Hydrochloride manufacturer or Butalamine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Butalamine Hydrochloride manufacturer or Butalamine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Butalamine Hydrochloride API Price utilized in the formulation of products. Butalamine Hydrochloride API Price is not always fixed or binding as the Butalamine Hydrochloride Price is obtained through a variety of data sources. The Butalamine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Butalamine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Butalamine Hydrochloride, including repackagers and relabelers. The FDA regulates Butalamine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Butalamine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Butalamine Hydrochloride supplier is an individual or a company that provides Butalamine Hydrochloride active pharmaceutical ingredient (API) or Butalamine Hydrochloride finished formulations upon request. The Butalamine Hydrochloride suppliers may include Butalamine Hydrochloride API manufacturers, exporters, distributors and traders.
Butalamine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Butalamine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Butalamine Hydrochloride GMP manufacturer or Butalamine Hydrochloride GMP API supplier for your needs.
A Butalamine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Butalamine Hydrochloride's compliance with Butalamine Hydrochloride specifications and serves as a tool for batch-level quality control.
Butalamine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Butalamine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Butalamine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Butalamine Hydrochloride EP), Butalamine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Butalamine Hydrochloride USP).
